Laboratory Confirmation of Lyme Disease

Lyme disease can be confirmed in the laboratory by isolation or detection of its causative agent, a tick-borne spirochete Borrelia burgdorferi, or by a diagnostic change in the titre of antibodies specific to the agent. B burgdorferi can be isolated and cultivated in Barbour-Stoenner-Kelly II medium...

Full description

Bibliographic Details
Main Authors: Tom G Schwan, Warren J Simpson, Patricia A Rosa
Format: Article
Language:English
Published: Hindawi Limited 1991-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1991/637201
id doaj-f33d369cd8e641b2badb38f0262962b4
record_format Article
spelling doaj-f33d369cd8e641b2badb38f0262962b42020-11-24T22:47:12ZengHindawi LimitedCanadian Journal of Infectious Diseases1180-23321991-01-0122646910.1155/1991/637201Laboratory Confirmation of Lyme DiseaseTom G Schwan0Warren J Simpson1Patricia A Rosa2Laboratory of Microbial Structure and Function, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USAArthropod-Borne Diseases Section, Laboratory of Vectors and Pathogens, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, USALaboratory of Microbial Structure and Function, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USALyme disease can be confirmed in the laboratory by isolation or detection of its causative agent, a tick-borne spirochete Borrelia burgdorferi, or by a diagnostic change in the titre of antibodies specific to the agent. B burgdorferi can be isolated and cultivated in Barbour-Stoenner-Kelly II medium. It can be detected by light microscopy in tissue sections or, rarely, in blood smears using various staining methods. There is interest in the development of alternative detection methods, including identification of specific antigens of B burgdorferi in the urine of suspected cases and demonstration of the presence of species-specific DNA using polymerase chain reaction assays. Currently, serological tests (indirect immunofluorescence assay, enzyme-linked immunosorbent assay and Western immunoblot) are the most practical and available methods for confirming Lyme disease. The quest to improve the specificity and sensitivity of serological tests – for example, through the use of specific recombinant antigens – continues.http://dx.doi.org/10.1155/1991/637201
collection DOAJ
language English
format Article
sources DOAJ
author Tom G Schwan
Warren J Simpson
Patricia A Rosa
spellingShingle Tom G Schwan
Warren J Simpson
Patricia A Rosa
Laboratory Confirmation of Lyme Disease
Canadian Journal of Infectious Diseases
author_facet Tom G Schwan
Warren J Simpson
Patricia A Rosa
author_sort Tom G Schwan
title Laboratory Confirmation of Lyme Disease
title_short Laboratory Confirmation of Lyme Disease
title_full Laboratory Confirmation of Lyme Disease
title_fullStr Laboratory Confirmation of Lyme Disease
title_full_unstemmed Laboratory Confirmation of Lyme Disease
title_sort laboratory confirmation of lyme disease
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases
issn 1180-2332
publishDate 1991-01-01
description Lyme disease can be confirmed in the laboratory by isolation or detection of its causative agent, a tick-borne spirochete Borrelia burgdorferi, or by a diagnostic change in the titre of antibodies specific to the agent. B burgdorferi can be isolated and cultivated in Barbour-Stoenner-Kelly II medium. It can be detected by light microscopy in tissue sections or, rarely, in blood smears using various staining methods. There is interest in the development of alternative detection methods, including identification of specific antigens of B burgdorferi in the urine of suspected cases and demonstration of the presence of species-specific DNA using polymerase chain reaction assays. Currently, serological tests (indirect immunofluorescence assay, enzyme-linked immunosorbent assay and Western immunoblot) are the most practical and available methods for confirming Lyme disease. The quest to improve the specificity and sensitivity of serological tests – for example, through the use of specific recombinant antigens – continues.
url http://dx.doi.org/10.1155/1991/637201
work_keys_str_mv AT tomgschwan laboratoryconfirmationoflymedisease
AT warrenjsimpson laboratoryconfirmationoflymedisease
AT patriciaarosa laboratoryconfirmationoflymedisease
_version_ 1725682546234097664